anti-STAT5B, pAb

CHF 315.00
In stock
YIF-LF-PA0069100 µlCHF 315.00
More Information
Product Details
Synonyms STAT5B; Signal Transducer and Activator of Transcription 5B
Product Type Polyclonal Antibody
Immunogen/Antigen Synthetic peptide.

Western Blot (1:20,000)

Crossreactivity Human
Purity Detail Protein A purified.
Formulation Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by AbFrontier
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF

Signal transducer and activator of transcription (STAT), named after their dual role, generally mediate cytokine, growth factor and hormone receptor signal transduction. In mammals, seven STAT proteins have been identified. STAT5 has been implicated in cellular functions of proliferation, differentiation and apoptosis with relevance to processes of hematopoiesis and immunoregulation, reproduction, and lipid metabolism. Two highly homologous STAT5 isoforms, 96kDa STAT5a and 94kDa STAT5b, are encoded by two tandemly linked genes. Although both STAT5 isoforms are roughly 95% homologous at the level of cDNA, they exhibit both redundant and non-redundant functions in vivo, probably due to differences in their transactivation domain. Aberrant regulation of STAT5 has been observed in solid tumors as well as in patients with either chronic or acute myeloid leukemia. Kinase inhibitors are currently being developed to negatively regulate STAT5 activity for clinical purposes. Carries out a dual function: signal transduction and activation of transcription. Binds to the GAS element and activates PRL-induced transcription.

Product References

1) Buitenhuis M, et al, Int J Biochem Cell Biol. 2004; vol.36(11) : pp.2120-4. (General)
2) Hendry L, John S. Eur J Biochem. 2004; vol.271(23-24): pp.4613-20. (General)
3) Shelburne CP, et al, Mol Immunol. 2002; vol.38(16-18): pp.1187-91. (General)
4) Grimley PM, et al, Cytokine Growth Factor Rev. 1999; vol.10(2): pp.131-57. (General)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.